Literature DB >> 17039652

Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.

Whitney P Bowe1, Jennifer C Filip, Joseph M DiRienzo, Alla Volgina, David J Margolis.   

Abstract

We report the in vitro inhibition of Propionibacterium acnes (P. acnes) by a bacteriocin-like inhibitory substance (BLIS-like substance) produced by Streptococcus salivarius (S. salivarius). Bacteriocins are proteinaceous substances produced by bacteria that are capable of inhibiting the growth of similar bacterial strains. Unlike classical antibiotics, they have a relatively narrow spectrum of killing activity, resulting in a reduction in the intensity of selection for resistance. These findings suggest that BLIS may potentially be used for its anti-P. acnes activity in the treatment of acne.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17039652      PMCID: PMC2739725     

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  30 in total

1.  MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens.

Authors:  M Mota-Meira; G LaPointe; C Lacroix; M C Lavoie
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

Review 2.  Association between antibiotic resistance and community prescribing: a critical review of bias and confounding in published studies.

Authors:  D Steinke; P Davey
Journal:  Clin Infect Dis       Date:  2001-09-15       Impact factor: 9.079

3.  Bacterial interference in the nasopharynx and nasal cavity of sinusitis prone and non-sinusitis prone children.

Authors:  I Brook; A E Gober
Journal:  Acta Otolaryngol       Date:  1999       Impact factor: 1.494

4.  Medication and medical service utilization for acne 1995-1998.

Authors:  R S Stern
Journal:  J Am Acad Dermatol       Date:  2000-12       Impact factor: 11.527

5.  Identification of Streptococcus salivarius by PCR and DNA probe.

Authors:  T Igarashi; Y Yano; A Yamamoto; R Sasa; N Goto
Journal:  Lett Appl Microbiol       Date:  2001-06       Impact factor: 2.858

6.  Increased carriage of resistant non-pneumococcal alpha-hemolytic streptococci after antibiotic therapy.

Authors:  F Ghaffar; I R Friedland; K Katz; L S Muniz; J L Smith; P Davis; J Reynolds; G H McCracken
Journal:  J Pediatr       Date:  1999-11       Impact factor: 4.406

7.  Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children.

Authors:  L Näse; K Hatakka; E Savilahti; M Saxelin; A Pönkä; T Poussa; R Korpela; J H Meurman
Journal:  Caries Res       Date:  2001 Nov-Dec       Impact factor: 4.056

8.  Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides.

Authors:  M Upton; J R Tagg; P Wescombe; H F Jenkinson
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

9.  Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.

Authors:  J R Tagg
Journal:  Indian J Med Res       Date:  2004-05       Impact factor: 2.375

10.  Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media?

Authors:  Tony Walls; Dan Power; John Tagg
Journal:  J Med Microbiol       Date:  2003-09       Impact factor: 2.472

View more
  16 in total

Review 1.  Anti-infective properties of bacteriocins: an update.

Authors:  Riadh Hammami; Benoit Fernandez; Christophe Lacroix; Ismail Fliss
Journal:  Cell Mol Life Sci       Date:  2012-10-30       Impact factor: 9.261

2.  Association of pharyngitis with oral antibiotic use for the treatment of acne: a cross-sectional and prospective cohort study.

Authors:  David J Margolis; Matthew Fanelli; Eli Kupperman; Maryte Papadopoulos; Joshua P Metlay; Sharon Xiangwen Xie; Joseph DiRienzo; Paul H Edelstein
Journal:  Arch Dermatol       Date:  2011-11-21

3.  Bacterial resistance to antibiotics in acne vulgaris: an in vitro study.

Authors:  Parvin Hassanzadeh; M Bahmani; Davood Mehrabani
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

4.  Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future?

Authors:  Whitney P Bowe; Alan C Logan
Journal:  Gut Pathog       Date:  2011-01-31       Impact factor: 4.181

Review 5.  The effect of probiotics on immune regulation, acne, and photoaging.

Authors:  Mary-Margaret Kober; Whitney P Bowe
Journal:  Int J Womens Dermatol       Date:  2015-04-06

Review 6.  Potential Role of the Microbiome in Acne: A Comprehensive Review.

Authors:  Young Bok Lee; Eun Jung Byun; Hei Sung Kim
Journal:  J Clin Med       Date:  2019-07-07       Impact factor: 4.241

7.  Putative Microbial Population Shifts Attributable to Nasal Administration of Streptococcus salivarius 24SMBc and Streptococcus oralis 89a.

Authors:  Roberta De Grandi; Lorenzo Drago; Alessandro Bidossi; Marta Bottagisio; Matteo Gelardi; Elena De Vecchi
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

8.  Evaluation of Bacterial Nanocellulose Membranes Loaded or Not with Nisin as a Complementary Treatment in Surgical Dehorning Wounds in Bovines.

Authors:  Fábio A F Custódio; Leonardo M de Castro; Erick Unterkircher; Ana Carolina R C Porto; Iolanda S Braga; Alessandre Hataka; Angela F Jozala; Denise Grotto
Journal:  Pharmaceutics       Date:  2021-05-11       Impact factor: 6.321

9.  Control of Propionibacterium acnes by natural antimicrobial substances: Role of the bacteriocin AS-48 and lysozyme.

Authors:  Rubén Cebrián; Sergio Arévalo; Susana Rubiño; Salvador Arias-Santiago; María Dolores Rojo; Manuel Montalbán-López; Manuel Martínez-Bueno; Eva Valdivia; Mercedes Maqueda
Journal:  Sci Rep       Date:  2018-08-06       Impact factor: 4.379

10.  The Effect of Oral Probiotic on the Interleukin-10 Serum Levels of Acne Vulgaris.

Authors:  Tissan Rahmayani; Imam Budi Putra; Nelva Karmilla Jusuf
Journal:  Open Access Maced J Med Sci       Date:  2019-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.